StonvexLoading…
StonvexStonvexStonvexCore line items from CYN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $218.98K | $368.14K | $1.49M | $262.00K |
Operating Income | $-25.69M | $-22.83M | $-23.35M | $-19.40M |
Net Income | $-23.47M | $-33.34M | $-22.81M | $-19.24M |
EPS (Diluted) | $-5.17 | $-2521.41 | $-6528.92 | $-0.55 |
Total Assets | $50.05M | $30.10M | $13.03M | $25.51M |
Total Liabilities | $11.30M | $31.14M | $2.40M | $1.39M |
Cash & Equivalents | $990.02K | $23.62M | $3.59M | $10.54M |
Free Cash Flow OCF − CapEx | $-24.81M | $-20.25M | $-20.52M | $-17.22M |
Shares Outstanding | 7.97M | 199.11K | 5.15K | 33.68M |